QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Vol. 19, Issue 7, 2818-2829, July 2008

This Article Full Text Full Text (PDF) All Versions of this Article: E07-09-0980v1 19/7/2818    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Mortensen, O. V. Articles by Amara, S. G. PubMed PubMed Citation Articles by Mortensen, O. V. Articles by Amara, S. G.

Genetic Complementation Screen Identifies a Mitogen-activated Protein Kinase Phosphatase, MKP3, as a Regulator of Dopamine Transporter Trafficking

Ole Valente Mortensen^*, Mads Breum Larsen^*, Balakrishna M. Prasad, and Susan G. Amara^*

*Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15260; and Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta, GA 30912

Submitted September 28, 2007; Revised April 3, 2008; Accepted April 16, 2008
Monitoring Editor: Jean Gruenberg

The antidepressant and cocaine sensitive plasma membrane monoamine transporters are the primary mechanism for clearance of their respective neurotransmitters and serve a pivotal role in limiting monoamine neurotransmission. To identify molecules in pathways that regulate dopamine transporter (DAT) internalization, we used a genetic complementation screen in Xenopus oocytes to identify a mitogen-activated protein (MAP) kinase phosphatase, MKP3/Pyst1/DUSP6, as a molecule that inhibits protein kinase C–induced (PKC) internalization of transporters, resulting in enhanced DAT activity. The involvement of MKP3 in DAT internalization was verified using both overexpression and shRNA knockdown strategies in mammalian cell models including a dopaminergic cell line. Although the isolation of MKP3 implies a role for MAP kinases in DAT internalization, MAP kinase inhibitors have no effect on internalization. Moreover, PKC-dependent down-regulation of DAT does not correlate with the phosphorylation state of several well-studied MAP kinases (ERK1/2, p38, and SAPK/JNK). We also show that MKP3 does not regulate PKC-induced ubiquitylation of DAT but acts at a more downstream step to stabilize DAT at the cell surface by blocking dynamin-dependent internalization and delaying the targeting of DAT for degradation. These results indicate that MKP3 can act to enhance DAT function and identifies MKP3 as a phosphatase involved in regulating dynamin-dependent endocytosis.

Address correspondence to: Ole Valente Mortensen (mortense{at}pitt.Edu)